Business and Economy

Business and Economy Latest News

Ozempic-maker Novo Nordisk says CEO to step down
Ozempic-maker Novo Nordisk says CEO to step down
by  AFP

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges". Novo Nordisk launched the anti-obesity drug Wegovy, which uses the same molecule but has been directly approved as a weight loss treatment, in the United States in 2021.

Money

Technology

Energy

Economy

Industry

Maritime

Capital Market